U.S. RESEARCH ROUNDUP- First Republic Bank, Jasper Therapeutics, MSCI

Onterris

16/01/2023 07:09

Jan 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on
several U.S.-listed companies, including First Republic Bank, Jasper Therapeutics and MSCI on Monday. 
  HIGHLIGHTS
                 * First Republic Bank  FRC.N : Piper Sandler raises target price to $130 from $125 
 
                 * Jasper Therapeutics Inc  JSPR.O : Credit Suisse raises target price to $3.5 from $3
 
                 * MSCI Inc  MSCI.N : Raymond James raises target price to $539 from $514 
 
 Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock
entries are in alphabetical order.
                 * Applied Digital Corp  APLD.O : Needham cuts target price to $3.7 from $5.5 
 
                 * BlackRock Inc  BLK.N : Credit Suisse cuts target price to $675 from $680 
 
                 * First Republic Bank  FRC.N : Credit Suisse cuts target price to $130 from $136 
 
                 * First Republic Bank  FRC.N : Piper Sandler raises target price to $130 from $125 
 
                 * First Republic Bank  FRC.N : Wells Fargo raises target price to $130 from $125 
 
                 * Jasper Therapeutics Inc  JSPR.O : Credit Suisse raises target price to $3.5 from $3 
 
                 * Montrose Environmental Group Inc  MEG.N : Needham raises target price to $58 from
 $48 
 
                 * MSCI Inc  MSCI.N : Raymond James raises target price to $539 from $514 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))